| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.098 | 0.03 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.58 | 0.04 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |